Status:
COMPLETED
Pectoral Nerve Block II and Erector Spine Plane Block in Breast Cancer Surgery
Lead Sponsor:
Ondokuz Mayıs University
Collaborating Sponsors:
CENGİZ KAYA (ckaya)
Conditions:
Anesthesia
Analgesia
Eligibility:
FEMALE
18-65 years
Phase:
NA
Brief Summary
This study evaluates the analgesic effects of pectoralis nerve block (PECS II) and erector spinae plane block (ESP) in patients having segmental mastectomy and sentinel lymph node biopsy (SLNB). Each ...
Detailed Description
It has been proven that PECS II and ESP both supply effective analgesia in the first 24 hours after mastectomy. But they do so by different mechanishms. This study is to survey that ESP and PECS II m...
Eligibility Criteria
Inclusion
- ASA 1-2 patients between the age of 18-65, scheduled for elective unilateral segmental mastectomy + sentinel lymph node biopsy
Exclusion
- Age \<18 or\> 65, ASA 3-4 patients
- Obesity (\> 100 kg, BMI\> 35 kg / m2)
- Patients undergoing bilateral mastectomy
- Pregnancy
- Contraindication of regional anesthesia (coagulopathy, abnormal INR, thrombocytopenia, infection at the injection site)
- Serious renal, cardiac, hepatic disease
- Hypersensitivity to local anesthetics or a history of allergy
- Patients with a history of opioid use longer than four weeks
- Patients with psychiatric disorders or communication difficulties
- Patients with chest deformity
- Patients with previous breast surgery except diagnostic biopsies
- Patients who do not want to participate
Key Trial Info
Start Date :
July 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2020
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04135157
Start Date
July 1 2019
End Date
September 1 2020
Last Update
August 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ondokuz Mayıs University Faculty of Medicine
Samsun, Turkey (Türkiye), 55270